Macquarie Heart
New South Wales, Australia
Cardiologist in Chatswood, New South Wales
Suite 901, Level 9, South Tower 1, Railway St, Chatswood NSW 2067
About Macquarie Heart
"Macquarie Heart is a leading cardiovascular group with an integrated network of cardiologists, vascular and endovascular surgeons and general physicians. Our Specialists include Dr Edward Barin, Dr Peter Caspari, Dr William Chik, Dr Ruba Haddad, Dr Alex Jacobsen, Dr Elizabeth Shaw, Dr Michael Stephen, Dr Richard Kerdic, Dr Daniel Nguyen, Dr Martin Cullen and Dr Sanaz Tehrani. We can accommodate urgent appointments for consultations and diagnostic testing."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Macquarie Heart
During the past decade, Macquarie Heart conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Assessment of Lesion Activity Analysis in the Avonex- Steroid Azathioprine (ASA) Study
2009-03-01
2014-12-01
Completed
159
A Longitudinal Study of Effect of Copaxone in RRMS Over 24 Months
2012-06-01
2013-02-01
Completed
60
A Longitudinal Study of Brain Atrophy in MS Patients Over 5 Years
2012-05-01
2013-02-01
Completed
60
Th Effects of Aubagio on Brain Pathology in Multiple Sclerosis Studied Over 12 Months
2013-06-01
2015-10-01
Completed
50
Studying the Effects of Copaxone on Retinal Health Using Optical Tomography Over 24 Months
2014-02-01
2014-12-01
Completed
100
Effects of Gilenya (Fingolimod) on Thalamus Pathology and Cognitive Impairment in Patients With Relapsing Forms of Multiple Sclerosis
2013-11-01
2018-10-01
Completed
50
Evaluate the Effect of Switching From Daily Injections of 20mg Glatiramer Acetate (GA) to 40mg GA Three Times a Week in Subjects With Relapsing-remitting Multiple Sclerosis
2014-07-01
2016-10-01
Completed
150
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Macquarie Heart
According to Clinical.Site data, the most researched conditions in "Macquarie Heart" are
"Advanced Cancer" (1 trials) and "Urothelial Cancer" (1 trials). Many other conditions were trialed in "Macquarie Heart" in a lesser frequency.
Clinical Trials Intervention Types at Macquarie Heart
Most popular intervention types in "Macquarie Heart" are "Biological" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Avelumab" (2 trials), "Best Supportive Care" (1 trials), "CMP-001" (1 trials), "Following the planned interim analysis for this study: Avelumab" (1 trials) and "PD 0360324" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Macquarie Heart
The vast majority of trials in "Macquarie Heart" are
2 trials for "All" genders.
Clinical Trials Status at Macquarie Heart
Currently, there are NaN active trials in "Macquarie Heart".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Macquarie Heart,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Macquarie Heart, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".